• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

screening

BioPharMEMS

LabCom grant for HCS Pharma, SMMiL-E team and IEMN

We are happy to tell you that HCS Pharma, SMMiL-E team (Seeding Microsystems in Medecine in Lille – European-Japanese Technologies against Cancer, CNRS UMI-2820 LIMMS/IIS) and Institut d’Electronique, de Micro-Electronique et de Nanotechnologie (IEMN) have successfully applied to a LabCom grant (‘COMmon LABoratory’)! A LabCom aims at gathering two entities Read more…

By Elodie Vandenhaute, 3 yearsJanuary 30, 2020 ago
News

Come to see Elodie on stand D6 @ NutrEvent 2019!

Elodie is waiting for you on the first floor at Nutr’event 2019! HCS Pharma stand is n° D6/2, on Clubster NHL pavilion. She will be glad to discuss with you about: our in vitro tests for the objectivation of your claims on human cells (e.g. nutraceutical, dermocosmetic claims) our innovative Read more…

By Elodie Vandenhaute, 3 yearsOctober 20, 2019 ago
HCS, HCA & Biology

SelectBio events on 3D culture and biochip systems last week : surprises and possibilities!

It was a great pleasure to be invited (thanks to our partner Molecular Devices) to present our work during these 2 events organized by selectBio in Rotterdam: Organoids and Tox Screening Europe 2019 on June 13-14 Organ-on-a-Chip and Tissue-on-a-Chip Europe 2019 on June 18-19 Both were of great interest for Read more…

By Grégory MAUBON, 4 yearsJune 26, 2019 ago
News

This month we welcome you in Rotterdam to talk about 3D cell culture technology for HCS

We will be present this week and next week in Rotterdam, to talk about 3D cell culture and the importance of the microenvironnement in the relevance of in vitro models. As you known, to mimic human tissues, several parameters need to be taken into account: the target cells, nutrient intake Read more…

By Grégory MAUBON, 4 yearsJune 10, 2019 ago
News

SLAS Europe in Brussels last week!

Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the 29th of June. Bringing together more than 1,000 academic and industry scientists from all around Read more…

By Elodie Vandenhaute, 5 yearsJuly 3, 2018 ago
News

Nathalie, our CEO, will present our activities at SIBS in Zurich

SIBS is the international conference on Image-Based Screening

By Grégory MAUBON, 5 yearsSeptember 28, 2017 ago
News

Find us at the next congress “Drug Discovery 2017” in Liverpool

The leading lights in drug discovery research across pharma, biotech, academia and the vendor community !

By Nathalie MAUBON, 5 yearsSeptember 21, 2017 ago
News

Validation of our new automation platform

Platform validation is in progress !

By Nathalie MAUBON, 5 yearsAugust 17, 2017 ago
In-Cosmetics Paris, April 12 to 14
News

In-Cosmetics Paris, April 12 to 14

Come and visit us at in-cosmetics, the meeting of the major groups of cosmetics, Porte de Versailles in Paris.

By Christophe Vermorel, 7 yearsMarch 18, 2016 ago
HCS, HCA & Biology

White paper about phenotypic screening in drugs discovery

« Phenotypic Drug Discovery with High Content Screening » by Permin Elmer

By Grégory MAUBON, 7 yearsNovember 24, 2015 ago
HCS, HCA & Biology

Screen Approaching using zebrafish embryos

Here is an interesting video from Department of Biological Sciences, University of Notre Dame, explaining how to do imaging on zebrafish embryos.

By Nathalie MAUBON, 8 yearsJanuary 1, 2015 ago
HCS, HCA & Biology

GPCR agonists search by HCS

This article highlights the value of high-content imaging in GPCR drug discovery efforts and emphasize the value of a multiassay approach to study pharmacological properties of compounds of interest.

By Nathalie MAUBON, 9 yearsMay 7, 2014 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • New 3D in vitro model of dysbiosis-induced colon cancer thanks to France Relance Plan
  • Retrospective HCS Pharma 2022
  • Animal tests no longer necessary before drug clinical trials? Let’s make it in 3D in preclinical studies… and with the extracellular matrix!
  • Tokyo Future Style Taiwan presented our BIOMIMESYS® products during Taiwan Healthcare Expo 2022
  • We were in Cosmet’Agora last week !
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid hydroscaffold imaging innovation in vitro in vitro models liver meeting Microbiota microscopy Molecular Devices NEUROCELL3D neurons neurotoxicity oncology organoids Parkinson phenotypic screening picture presentation screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...